{"id":"placebo-for-dabigatran","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site reaction"}]},"_chembl":{"chemblId":"CHEMBL539697","moleculeType":"Small molecule","molecularWeight":"627.75"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"A placebo is a dummy treatment that has no therapeutic effect. It is used as a control in clinical trials to compare the efficacy of active treatments.","oneSentence":"Placebo does not have a pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:59.740Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"}]},"trialDetails":[{"nctId":"NCT06945276","phase":"PHASE1","title":"Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-05-13","conditions":"COVID-19","enrollment":51},{"nctId":"NCT06533280","phase":"PHASE1","title":"VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)","status":"WITHDRAWN","sponsor":"ViiV Healthcare","startDate":"2024-08-02","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT03752294","phase":"PHASE1","title":"A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.","status":"WITHDRAWN","sponsor":"University of Rhode Island","startDate":"2019-05","conditions":"Mild Cognitive Impairment, Mild Alzheimer's Disease","enrollment":""},{"nctId":"NCT06615596","phase":"EARLY_PHASE1","title":"Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-01","conditions":"Atrial Fibrillation (AF)","enrollment":3160},{"nctId":"NCT02067182","phase":"PHASE4","title":"Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation","status":"COMPLETED","sponsor":"Georg Nickenig","startDate":"2015-08","conditions":"Atrial Fibrillation, Cardioembolic Events, Oral Anticoagulation","enrollment":200},{"nctId":"NCT04433481","phase":"NA","title":"Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-06-20","conditions":"Liver Cirrhosis, Portal Vein Thrombosis","enrollment":84},{"nctId":"NCT02239120","phase":"PHASE3","title":"Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-11-27","conditions":"Stroke, Secondary Prevention","enrollment":5390},{"nctId":"NCT01661101","phase":"PHASE3","title":"Management of Myocardial Injury After Noncardiac Surgery Trial","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2013-01","conditions":"Myocardial Injury After Noncardiac Surgery (MINS)","enrollment":1754},{"nctId":"NCT02463591","phase":"PHASE2","title":"Reversal of Dabigatran With Prothrombin Complex Concentrate","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2015-01","conditions":"Drug Action Reversal","enrollment":12},{"nctId":"NCT02313584","phase":"PHASE3","title":"Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk","status":"UNKNOWN","sponsor":"Korea University","startDate":"2014-12","conditions":"Atrial Fibrillation, Thromboembolism","enrollment":464},{"nctId":"NCT02170831","phase":"PHASE1","title":"Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1999-05","conditions":"Healthy","enrollment":40},{"nctId":"NCT00329238","phase":"PHASE3","title":"Secondary Prevention of Venous Thrombo Embolism (VTE).","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-05","conditions":"Thromboembolism","enrollment":2867},{"nctId":"NCT00680186","phase":"PHASE3","title":"Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-04","conditions":"Thromboembolism","enrollment":2589},{"nctId":"NCT01225822","phase":"PHASE2","title":"BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-11","conditions":"Venous Thromboembolism","enrollment":1973},{"nctId":"NCT00621855","phase":"PHASE2","title":"RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-03","conditions":"Coronary Disease","enrollment":1878}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo (for Dabigatran)","genericName":"Placebo (for Dabigatran)","companyName":"Population Health Research Institute","companyId":"population-health-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo does not have a pharmacological effect. Used for Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}